CellTrans Inc.: Clinical Trials

1 trial sponsored by CellTrans Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow CellTrans Inc.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Islets of Langerhans transplantation - Type 1 Diabetes Mellitus
Phase 3CompletedCellTrans Inc.212007-09-052026-11-04

Conditions studied

Diabetes Mellitus, Type 1 (1)

Interventions

Basiliximab (1)  ·  Etanercept (1)  ·  Exenatide (1)  ·  Islets of Langerhans Transplantation (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)

Countries

United States (1)

Top investigators

Jose Oberholzer, MD (1)

Results publications

PMID 29779835, PMID 39735417